Finland· FI-REL-REL13245
Ceprotin
A protein c product containing human protein c, registered in Finland by Baxter AG. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Protein c is registered in 9 of 19 countries.
Countries holding a registration under ATC B01AD12 (protein c), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Protein c · ATC B01AD12
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Human protein C
- Manufacturer
- Baxter AG
- Country
- Finland (FI)
- ATC code
- B01AD12
- ATC class
- Protein C
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
34 interactions on record for protein c.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Protein c · interactions on record
34 records
- 1 severe
- 33 moderate
Most severe, free to view
- CaplacizumabB01AX07severe
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- HeparinB01AB01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Protein c in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceCEPROTIN 1000 UI/10 ml, poudre et solvant pour solution injectableTAKEDA MANUFACTURING AUSTRIA (AUTRICHE)
- BelgiumCeprotin 1000 IUTakeda Manufacturing Austria
- CzechiaCEPROTINTakeda Manufacturing Austria AG, Vídeň
- United KingdomCeprotin 1000unit powder and solvent for solution for injection vialsTakeda UK Ltd
- IrelandCeprotinBaxter Vaccine AG
- IcelandCeprotinBaxter AG*
- SwedenCeprotin 1000 IE Pulver och vätska till injektionsvätska, lösningTakeda Manufacturing Austria AG
- SwitzerlandCeprotin 1000 I.E., Pulver und Lösungsmittel zur Herstellung einer InjektionslösungTakeda Pharma AG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- France · Protexel
- Iceland · Ceprotin
- Liechtenstein · Ceprotin
- Norway · Ceprotin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc48c9ee-1263-422a-b848-8cdf14ae8807 GET /v1/drugs/dc48c9ee-1263-422a-b848-8cdf14ae8807?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokuiva-aine ja liuotin, liuosta varten",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "1000 IU",
"atc_label": "proteiini C",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/01/190/002",
"fimea_rel_id": "REL13245",
"authorised_at": "2001-07-16"
}See everything about protein c.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.